Lynda B. Davern

Protective immunization against experimental Bacteroides (Porphyromonas) gingivalis infection

P B Chen, Lynda B. Davern, Robert E. Schifferle et al. · Infection and Immunity · 1990 · 69 citations · Full text

Secondary Lesions, Mucosal Vaccination, Microbial Disease +10

Phosphorylation and calcium influx are not sufficient for the activation of cytosolic phospholipase A2 in U937 cells: Requirement for a Giα-type G-protein

James R. Burke, Lynda B. Davern, Kurt R. Gregor et al. · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · 1997 · 42 citations

U937 Cells, Protein Function, Signal Transduction +13

BMS-229724 Is a Tight-Binding Inhibitor of Cytosolic Phospholipase A2 That Acts at the Lipid/Water Interface and Possesses Anti-Inflammatory Activity in Skin Inflammation Models

James R. Burke, Lynda B. Davern, Paul Stanley et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 31 citations

Host responses induced by co‐infection with <i>Porphyromonas gingivalis</i> and <i>Actinobacillus actinomycetemcomitans</i> in a murine model

P. B. Chen, Lynda B. Davern, Jannet Katz et al. · Oral Microbiology and Immunology · 1996 · 29 citations

Inhibitor of phospholipase A2 blocks eicosanoid and platelet activating factor biosynthesis and has topical anti-inflammatory activity.

Kenneth M. Tramposch, Floyd H. Chilton, Paul Stanley et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 29 citations